Log In
Print this Print this

formerly SB-656933

Also known as: 656933

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCXC chemokine receptor 2 (CXCR2) antagonist
Molecular Target CXC chemokine receptor 2 (CXCR2) (IL8RB)
Mechanism of ActionCXC chemokine receptor 2 (CXCR2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today